BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20514604)

  • 1. Body composition after endogenous (Cushing's syndrome) and exogenous (rheumatoid arthritis) exposure to glucocorticoids.
    Resmini E; Farkas C; Murillo B; Barahona MJ; Santos A; Martínez-Momblán MA; Roig O; Ybarra J; Geli C; Webb SM
    Horm Metab Res; 2010 Jul; 42(8):613-8. PubMed ID: 20514604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the metabolic phenotypes of Cushing's syndrome and growth hormone deficiency: a study of body composition and energy metabolism.
    Burt MG; Gibney J; Ho KK
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):436-43. PubMed ID: 16584517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deleterious effects of glucocorticoid replacement on bone in women after long-term remission of Cushing's syndrome.
    Barahona MJ; Sucunza N; Resmini E; Fernández-Real JM; Ricart W; Moreno-Navarrete JM; Puig T; Wägner AM; Rodriguez-Espinosa J; Farrerons J; Webb SM
    J Bone Miner Res; 2009 Nov; 24(11):1841-6. PubMed ID: 19453254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis.
    Toussirot E; Nguyen NU; Dumoulin G; Aubin F; Cédoz JP; Wendling D
    Rheumatology (Oxford); 2005 Jan; 44(1):120-5. PubMed ID: 15466894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent association of increased trunk fat with increased arterial stiffening in postmenopausal patients with rheumatoid arthritis.
    Inaba M; Tanaka K; Goto H; Sakai S; Yamada S; Naka H; Imanishi Y; Nishizawa Y
    J Rheumatol; 2007 Feb; 34(2):290-5. PubMed ID: 17304655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body composition and bone mineral density in women with Cushing's syndrome in remission and the association with common genetic variants influencing glucocorticoid sensitivity.
    Ragnarsson O; Glad CA; Bergthorsdottir R; Almqvist EG; Ekerstad E; Widell H; Wängberg B; Johannsson G
    Eur J Endocrinol; 2015 Jan; 172(1):1-10. PubMed ID: 25422351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in body composition after glucocorticoid therapy in patients with systemic lupus erythematosus.
    Mok CC; To CH; Ma KM
    Lupus; 2008 Nov; 17(11):1018-22. PubMed ID: 18852226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body composition, bone mineral density, and circulating leptin levels in postmenopausal Turkish women.
    Sahin G; Polat G; Baethiş S; Milcan A; Baethdatoethlu O; Erdoethan C; Camdeviren H
    Rheumatol Int; 2003 Mar; 23(2):87-91. PubMed ID: 12634942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of body composition and bone mineral density in women with rheumatoid arthritis].
    Silva RG; Pippa MG; Zerbin CA
    Rev Assoc Med Bras (1992); 2007; 53(2):135-41. PubMed ID: 17568917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein metabolism in glucocorticoid excess: study in Cushing's syndrome and the effect of treatment.
    Burt MG; Gibney J; Ho KK
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1426-32. PubMed ID: 17244724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between body composition and bone mineral density (BMD) in perimenopausal Korean women.
    Kim CJ; Oh KW; Rhee EJ; Kim KH; Jo SK; Jung CH; Won JC; Park CY; Lee WY; Park SW; Kim SW
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):18-26. PubMed ID: 19178508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soft tissue composition, axial bone mineral density, and grip strength in postmenopausal Turkish women with early rheumatoid arthritis: Is lean body mass a predictor of bone mineral density in rheumatoid arthritis?
    Sahin G; Guler H; Incel N; Sezgin M; As I
    Int J Fertil Womens Med; 2006; 51(2):70-4. PubMed ID: 16881382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precedence of the shift of body-fat distribution over the change in body composition after menopause.
    Morita Y; Iwamoto I; Mizuma N; Kuwahata T; Matsuo T; Yoshinaga M; Douchi T
    J Obstet Gynaecol Res; 2006 Oct; 32(5):513-6. PubMed ID: 16984520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early rheumatoid arthritis and body composition.
    Book C; Karlsson MK; Akesson K; Jacobsson LT
    Rheumatology (Oxford); 2009 Sep; 48(9):1128-32. PubMed ID: 19602478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis.
    Book C; Karlsson M; Akesson K; Jacobsson L
    Scand J Rheumatol; 2008; 37(4):248-54. PubMed ID: 18612924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.
    Lange U; Teichmann J; Müller-Ladner U; Strunk J
    Rheumatology (Oxford); 2005 Dec; 44(12):1546-8. PubMed ID: 16263785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid arthritis: evidence for bone loss in premenopausal women.
    Tourinho TF; Stein A; Castro JA; Brenol JC
    J Rheumatol; 2005 Jun; 32(6):1020-5. PubMed ID: 15940761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
    Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
    Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease.
    Johannsson G; Sunnerhagen KS; Svensson J
    Clin Endocrinol (Oxf); 2004 May; 60(5):550-9. PubMed ID: 15104557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.